DeepLook Medical Announces First Close of Series A and Releases
FEATURED IN
- Sep 17
DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
- Mar 5
UK Regulatory Approval for DL Precise™ Software
- Feb 7
DeepLook Medical Secures $1.7 Million to Revolutionize Cancer Detection in Dense Breasts
- Dec 6, 2023
CEO Marissa Fayer Named in MDID Top 24 Medtech Voices to Follow
- Nov 6, 2023
CEO Marissa Fayer to speak Nov 8 at Frost & Sullivan: EmpowerHER
- Oct 25, 2023
Tidal River Fund Invests in DeepLook
- Oct 21, 2023
CEO Marissa Fayer Speaks at AdvaMed's Annual Conference
- Oct 9, 2023
DeepLook Included in AARP Age Tech Collaborative Fall 2023 Cohort
- Sep 19, 2023
CEO Marissa Fayer Speaks at Women's Health Innovation Summit
- May 15, 2023
DeepLook Wins the AgeTech Collaborative by AARP and Portfolia Contest
- May 6, 2023
CEO & CSO Attend Society of Breast Imaging
- Apr 28, 2023
CEO Marissa Fayer Gives Keynote Address at MassMedic Impact Symposium on Women's Health
- Mar 6, 2023
The FDA issues new ruling requiring “dense breast” reporting to women and their referring providers
- Oct 30, 2022
DeepLook Named One of Top Women-Led MedTech Start-ups
- Oct 24, 2022
De-masking Density
- Oct 22, 2022
CEO Addresses Conference on Outsourcing Clinical Trials
- Sep 1, 2021
Nominee for Best New Radiology Software
- Jul 8, 2021
FDA Clears One-Click Segmentation & Measurement Tool
©2024 by DeepLook Medical